Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis

doi:10.3748/wjg.v26.i45.7204

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 45

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6745)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

374

WORD

204

HTML

2872

Figures (1-5)

419

Tables (1-3)

304

Sum=4173

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

648

Download

1924

Sum=2572

Dec 7, 2020 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 7, 2020; 26(45): 7204-7221
Published online Dec 7, 2020. doi: 10.3748/wjg.v26.i45.7204

Table 1 Patient’s clinical characteristics of the training and validation cohort

Variable	Training cohort (n = 123)	Validation cohort (n = 184)	P value
Clinical parameter
Age (yr)	54.05 ± 12.02	54.54 ± 12.25	0.727
Male (%)	96 (78.05)	147 (79.89)	0.697
BMI (kg/m²)	22.97 ± 3.24	22.91 ± 3.41	0.877
SBP (mmHg)	129.29 ± 20.62	129.03 ± 20.56	0.914
DBP (mmHg)	71.77 ± 12.16	71.41 ± 11.76	0.796
Child-Pugh class A (%)	58 (47.15)	86 (46.74)	0.943
Degree of EV (Q1, Q3)	2 (0, 3)	2 (0, 3)	0.873
0 (%)	32 (26.02)	48 (26.09)
1 (%)	16 (13.01)	26 (14.13)
2 (%)	21 (17.07)	25 (13.59)
3 (%)	54 (43.90)	85 (46.19)
Laboratory test
TBil (µmol/L)	19.00 (12.00, 31.00)	18.50 (12.00, 31.00)	0.943
DBil (µmol/L)	9.00 (5.00, 16.00)	9.00 (5.00, 17.00)	0.766
TP (g/L)	65.80 ± 10.03	66.05 ± 9.95	0.831
Albumin (g/L)	32.85 ± 7.11	33.14 ± 7.14	0.726
ALT (IU/L)	27.00 (20.00, 47.00)	27.50 (20.25, 47.00)	0.850
AST (IU/L)	38.00 (28.00, 70.00)	41.00 (28.00, 70.75)	0.734
ALP (IU/L)	94.00 (74.00, 131.00)	99.00 (73.00, 140.00)	0.728
GGT (IU/L)	51.00 (24.00, 126.00)	50.00 (29.25, 126.75)	0.865
INR	1.36 (1.17, 1.54)	1.36 (1.17, 1.54)	0.994
PLT (× 10⁹/L)	82.00 (53.00, 140.00)	84.00 (56.00, 139.00)	0.760
MPV (fl)	11.50 (10.50, 12.50)	11.30 (10.40, 12.30)	0.301
PDW (fl)	14.90 (12.60, 17.30)	14.65 (12.70, 17.18)	0.760
Ultrasound parameter
HAD (mm)	3.46 ± 0.56	3.47 ± 0.57	0.914
HAPV (cm/s)	50.35 ± 12.23	50.51 ± 13.33	0.915
PVD (mm)	12.30 ± 1.54	12.05 ± 1.61	0.186
MPVV (cm/s)	19.11 ± 5.28	19.93 ± 5.59	0.196
SAD (mm)	5.05 ± 1.00	5.00 ± 0.98	0.678
SAPV (cm/s)	55.89 ± 15.38	55.91 ± 16.03	0.990
SVD (mm)	9.61 ± 1.82	9.59 ± 1.70	0.899
MSVV (cm/s)	22.22 ± 4.93	22.69 ± 5.20	0.428
ST (mm)	44.47 ± 9.36	44.61 ± 9.68	0.900
SD (mm)	110.88 ± 23.73	112.27 ± 25.39	0.629
SPI	2.96 ± 1.75	2.92 ± 1.96	0.871
LFI	3.74 ± 0.69	3.72 ± 0.68	0.886

BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; EV: Esophageal varices; Q1: 1^st quartile; Q3: 3^rd quartile; TBil: Total bilirubin; DBil: Direct bilirubin; TP: Total protein; ALT: Alanine transaminase; AST: Aspartic transaminase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transpeptidase; INR: International normalized ratio; PLT: Platelet count; MPV: Mean platelet volume; PDW: Platelet distribution width; HAD: Hepatic artery diameter; HAPV: Hepatic artery peak velocity; PVD: Portal vein diameter; MPVV: Mean portal vein velocity; SAD: Splenic artery diameter; SAPV: Splenic artery peak velocity; SVD: Splenic vein diameters; MSVV: Mean splenic vein velocity; ST: Spleen thick; SD: Spleen diameter; SPI: Splenic portal index; LFI: Liver fibrosis index.

Table 2 Univariate and multivariate logistic regression analyses for esophageal varices risk in patients with chronic hepatitis B related cirrhosis in the training cohort

Variable	Univariate analysis			Multivariate analysis
Variable	OR	95%CI	P value	OR	95%CI	P value
Clinical parameter
Age (yr)	1.038	1.001-1.076	0.043
Gender (Female = 0, Male = 1)	0.994	0.375-2.633	0.990
BMI (kg/m²)	1.031	0.907-1.171	0.643
SBP (mmHg)	1.005	0.985-1.025	0.657
DBP (mmHg)	0.985	0.953-1.018	0.367
Child-Pugh class	7.990	2.979-21.426	< 0.001	7.705	2.169-27.370	0.002
(Child A = 1, Child B/C = 2)
Laboratory test
TBil (µmol/L)	1.001	0.988-1.013	0.930
DBil (µmol/L)	0.998	0.981-1.016	0.831
TP (g/L)	0.976	0.936-1.018	0.255
Albumin (g/L)	0.932	0.877-0.990	0.022
ALT (IU/L)	0.992	0.984-1.000	0.052
AST (IU/L)	0.997	0.990-1.003	0.294
ALP (IU/L)	1.009	0.999-1.018	0.065
GGT (IU/L)	0.998	0.995-1.000	0.081
INR	20.331	2.870-144.037	0.003
PLT (× 10⁹/L)	0.990	0.985-0.995	< 0.001	0.992	0.984-1.000	0.044
MPV (fl)	1.373	0.999-1.887	0.051
PDW (fl)	1.128	0.981-1.297	0.092
Ultrasound parameter
HAD (mm)	1.619	0.786-3.335	0.192
HAPV (cm/s)	1.017	0.984-1.051	0.318
PVD (mm)	1.505	1.121-2.021	0.006
MPVV (cm/s)	0.915	0.845-0.991	0.029
SAD (mm)	0.935	0.629-1.390	0.740
SAPV (cm/s)	0.995	0.970-1.021	0.711
SVD (mm)	1.086	0.860-1.372	0.489
MSVV (cm/s)	1.073	0.977-1.180	0.142
ST (mm)	1.312	1.178-1.462	< 0.001
SD (mm)	1.036	1.012-1.059	0.003
SPI	4.183	2.044-8.559	< 0.001	3.895	1.630-9.308	0.002
LFI	7.067	2.938-16.995	< 0.001	3.603	1.336-9.719	0.011

The bold P values represent P < 0.05. OR: Odds ratio; 95%CI: 95% Confidence interval; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; TBil: Total bilirubin; DBil: Direct bilirubin; TP: Total protein; ALT: Alanine transaminase; AST: Aspartic transaminase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyl transpeptidase; INR: International normalized ratio; PLT: Platelet count; MPV: Mean platelet volume; PDW: Platelet distribution width; HAD: Hepatic artery diameter; HAPV: Hepatic artery peak velocity; PVD: Portal vein diameter; MPVV: Mean portal vein velocity; SAD: Splenic artery diameter; SAPV: Splenic artery peak velocity; SVD: Splenic vein diameters; MSVV: Mean splenic vein velocity; ST: Spleen thick; SD: Spleen diameter; SPI: Splenic portal index; LFI: Liver fibrosis index.

Table 3 Univariate and multivariate logistic regression analyses for esophageal varices severity in patients with chronic hepatitis B related cirrhosis in the training cohort

Variable	Univariate analysis			Multivariate analysis
Variable	OR	95%CI	P value	OR	95%CI	P value
Clinical parameter
Age (yr)	0.997	0.967-1.027	0.833
Gender (Female = 0, Male = 1)	0.898	0.372-2.168	0.811
BMI (kg/m²)	1.011	0.904-1.132	0.844
SBP (mmHg)	1.001	0.983-1.019	0.928
DBP (mmHg)	0.992	0.962-1.022	0.584
Child-Pugh class	5.161	2.344-11.361	< 0.001	5.436	2.112-13.990	< 0.001
(Child A = 1, Child B/C = 2)
Laboratory test
TBil (µmol/L)	1.000	0.989-1.012	0.937
DBil (µmol/L)	0.996	0.980-1.012	0.643
TP (g/L)	0.978	0.942-1.015	0.246
Albumin (g/L)	0.987	0.937-1.038	0.605
ALT (IU/L)	0.994	0.986-1.001	0.109
AST (IU/L)	0.997	0.991-1.003	0.282
ALP (IU/L)	1.001	0.995-1.007	0.637
GGT (IU/L)	0.997	0.995-1.000	0.064
INR	10.764	2.342-49.469	0.002
PLT (× 10⁹/L)	0.994	0.989-0.999	0.016
MPV (fl)	1.399	1.050-1.865	0.022	1.479	1.043-2.098	0.028
PDW (fl)	1.036	0.920-1.166	0.564
Ultrasound parameter
HAD (mm)	1.327	0.693-2.541	0.393
HAPV (cm/s)	1.025	0.995-1.057	0.108
PVD (mm)	1.465	1.126-1.906	0.004	1.397	1.021-1.912	0.037
MPVV (cm/s)	0.964	0.899-1.033	0.301
SAD (mm)	0.973	0.678-1.396	0.880
SAPV (cm/s)	1.000	0.977-1.024	0.985
SVD (mm)	1.109	0.900-1.366	0.332
MSVV (cm/s)	1.062	0.979-1.151	0.148
ST (mm)	1.146	1.077-1.218	< 0.001
SD (mm)	1.030	1.010-1.049	0.003
SPI	1.644	1.193-2.265	0.002	1.463	1.030-2.079	0.034
LFI	4.184	2.080-8.416	< 0.001	3.089	1.442-6.617	0.004

Citation: Xu SH, Wu F, Guo LH, Zhang WB, Xu HX. Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis. World J Gastroenterol 2020; 26(45): 7204-7221
URL: https://www.wjgnet.com/1007-9327/full/v26/i45/7204.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i45.7204